Global MET TKIs Market Growth 2026-2032
The global MET TKIs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
MET tyrosine kinase inhibitors (TKIs) are targeted therapies designed to block the activity of the MET receptor tyrosine kinase.These inhibitors, including drugs like crizotinib, capmatinib, and tepotinib, are used to treat cancers with MET alterations, such as non-small cell lung cancer (NSCLC) and gastric cancer.
United States market for MET TKIs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for MET TKIs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for MET TKIs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key MET TKIs players cover Pfizer, Novartis, Merck, Exelixis, Haihe Biopharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “MET TKIs Industry Forecast” looks at past sales and reviews total world MET TKIs sales in 2025, providing a comprehensive analysis by region and market sector of projected MET TKIs sales for 2026 through 2032. With MET TKIs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world MET TKIs industry.
This Insight Report provides a comprehensive analysis of the global MET TKIs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on MET TKIs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global MET TKIs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for MET TKIs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global MET TKIs.
This report presents a comprehensive overview, market shares, and growth opportunities of MET TKIs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global MET TKIs market?
What factors are driving MET TKIs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do MET TKIs market opportunities vary by end market size?
How does MET TKIs break out by Type, by Application?
MET tyrosine kinase inhibitors (TKIs) are targeted therapies designed to block the activity of the MET receptor tyrosine kinase.These inhibitors, including drugs like crizotinib, capmatinib, and tepotinib, are used to treat cancers with MET alterations, such as non-small cell lung cancer (NSCLC) and gastric cancer.
United States market for MET TKIs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for MET TKIs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for MET TKIs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key MET TKIs players cover Pfizer, Novartis, Merck, Exelixis, Haihe Biopharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “MET TKIs Industry Forecast” looks at past sales and reviews total world MET TKIs sales in 2025, providing a comprehensive analysis by region and market sector of projected MET TKIs sales for 2026 through 2032. With MET TKIs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world MET TKIs industry.
This Insight Report provides a comprehensive analysis of the global MET TKIs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on MET TKIs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global MET TKIs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for MET TKIs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global MET TKIs.
This report presents a comprehensive overview, market shares, and growth opportunities of MET TKIs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Multi-target Inhibitors
- Single-target Inhibitors
- Non-small Cell Lung Cancer
- Medullary Thyroid Cancer
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Novartis
- Merck
- Exelixis
- Haihe Biopharma
- CSPC Pharmaceutical
- WuXi STA
- Shanghai Hutchison Pharmaceuticals
- Avistone Pharmaceuticals Biotechnology
- Asymchem
- Wanbang Biopharmaceuticals
- Drug International
- Genvio Pharma
- Everest Pharmaceuticals
- Beacom
- Teva
- Cipla
- BDR Pharma
- Zydus
What is the 10-year outlook for the global MET TKIs market?
What factors are driving MET TKIs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do MET TKIs market opportunities vary by end market size?
How does MET TKIs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global MET TKIs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for MET TKIs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for MET TKIs by Country/Region, 2021, 2025 & 2032
2.2 MET TKIs Segment by Type
2.2.1 Multi-target Inhibitors
2.2.2 Single-target Inhibitors
2.2.3 MET TKIs Sales by Type
2.2.3.1 Global MET TKIs Sales Market Share by Type (2021-2026)
2.2.3.2 Global MET TKIs Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global MET TKIs Sale Price by Type (2021-2026)
2.3 MET TKIs Segment by Application
2.3.1 Non-small Cell Lung Cancer
2.3.2 Medullary Thyroid Cancer
2.3.3 Other
2.3.4 MET TKIs Sales by Application
2.3.4.1 Global MET TKIs Sale Market Share by Application (2021-2026)
2.3.4.2 Global MET TKIs Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global MET TKIs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global MET TKIs Breakdown Data by Company
3.1.1 Global MET TKIs Annual Sales by Company (2021-2026)
3.1.2 Global MET TKIs Sales Market Share by Company (2021-2026)
3.2 Global MET TKIs Annual Revenue by Company (2021-2026)
3.2.1 Global MET TKIs Revenue by Company (2021-2026)
3.2.2 Global MET TKIs Revenue Market Share by Company (2021-2026)
3.3 Global MET TKIs Sale Price by Company
3.4 Key Manufacturers MET TKIs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers MET TKIs Product Location Distribution
3.4.2 Players MET TKIs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MET TKIS BY GEOGRAPHIC REGION
4.1 World Historic MET TKIs Market Size by Geographic Region (2021-2026)
4.1.1 Global MET TKIs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global MET TKIs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic MET TKIs Market Size by Country/Region (2021-2026)
4.2.1 Global MET TKIs Annual Sales by Country/Region (2021-2026)
4.2.2 Global MET TKIs Annual Revenue by Country/Region (2021-2026)
4.3 Americas MET TKIs Sales Growth
4.4 APAC MET TKIs Sales Growth
4.5 Europe MET TKIs Sales Growth
4.6 Middle East & Africa MET TKIs Sales Growth
5 AMERICAS
5.1 Americas MET TKIs Sales by Country
5.1.1 Americas MET TKIs Sales by Country (2021-2026)
5.1.2 Americas MET TKIs Revenue by Country (2021-2026)
5.2 Americas MET TKIs Sales by Type (2021-2026)
5.3 Americas MET TKIs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC MET TKIs Sales by Region
6.1.1 APAC MET TKIs Sales by Region (2021-2026)
6.1.2 APAC MET TKIs Revenue by Region (2021-2026)
6.2 APAC MET TKIs Sales by Type (2021-2026)
6.3 APAC MET TKIs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe MET TKIs by Country
7.1.1 Europe MET TKIs Sales by Country (2021-2026)
7.1.2 Europe MET TKIs Revenue by Country (2021-2026)
7.2 Europe MET TKIs Sales by Type (2021-2026)
7.3 Europe MET TKIs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa MET TKIs by Country
8.1.1 Middle East & Africa MET TKIs Sales by Country (2021-2026)
8.1.2 Middle East & Africa MET TKIs Revenue by Country (2021-2026)
8.2 Middle East & Africa MET TKIs Sales by Type (2021-2026)
8.3 Middle East & Africa MET TKIs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of MET TKIs
10.3 Manufacturing Process Analysis of MET TKIs
10.4 Industry Chain Structure of MET TKIs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 MET TKIs Distributors
11.3 MET TKIs Customer
12 WORLD FORECAST REVIEW FOR MET TKIS BY GEOGRAPHIC REGION
12.1 Global MET TKIs Market Size Forecast by Region
12.1.1 Global MET TKIs Forecast by Region (2027-2032)
12.1.2 Global MET TKIs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global MET TKIs Forecast by Type (2027-2032)
12.7 Global MET TKIs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer MET TKIs Product Portfolios and Specifications
13.1.3 Pfizer MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis MET TKIs Product Portfolios and Specifications
13.2.3 Novartis MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck MET TKIs Product Portfolios and Specifications
13.3.3 Merck MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Exelixis
13.4.1 Exelixis Company Information
13.4.2 Exelixis MET TKIs Product Portfolios and Specifications
13.4.3 Exelixis MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Exelixis Main Business Overview
13.4.5 Exelixis Latest Developments
13.5 Haihe Biopharma
13.5.1 Haihe Biopharma Company Information
13.5.2 Haihe Biopharma MET TKIs Product Portfolios and Specifications
13.5.3 Haihe Biopharma MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Haihe Biopharma Main Business Overview
13.5.5 Haihe Biopharma Latest Developments
13.6 CSPC Pharmaceutical
13.6.1 CSPC Pharmaceutical Company Information
13.6.2 CSPC Pharmaceutical MET TKIs Product Portfolios and Specifications
13.6.3 CSPC Pharmaceutical MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 CSPC Pharmaceutical Main Business Overview
13.6.5 CSPC Pharmaceutical Latest Developments
13.7 WuXi STA
13.7.1 WuXi STA Company Information
13.7.2 WuXi STA MET TKIs Product Portfolios and Specifications
13.7.3 WuXi STA MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 WuXi STA Main Business Overview
13.7.5 WuXi STA Latest Developments
13.8 Shanghai Hutchison Pharmaceuticals
13.8.1 Shanghai Hutchison Pharmaceuticals Company Information
13.8.2 Shanghai Hutchison Pharmaceuticals MET TKIs Product Portfolios and Specifications
13.8.3 Shanghai Hutchison Pharmaceuticals MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Shanghai Hutchison Pharmaceuticals Main Business Overview
13.8.5 Shanghai Hutchison Pharmaceuticals Latest Developments
13.9 Avistone Pharmaceuticals Biotechnology
13.9.1 Avistone Pharmaceuticals Biotechnology Company Information
13.9.2 Avistone Pharmaceuticals Biotechnology MET TKIs Product Portfolios and Specifications
13.9.3 Avistone Pharmaceuticals Biotechnology MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Avistone Pharmaceuticals Biotechnology Main Business Overview
13.9.5 Avistone Pharmaceuticals Biotechnology Latest Developments
13.10 Asymchem
13.10.1 Asymchem Company Information
13.10.2 Asymchem MET TKIs Product Portfolios and Specifications
13.10.3 Asymchem MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Asymchem Main Business Overview
13.10.5 Asymchem Latest Developments
13.11 Wanbang Biopharmaceuticals
13.11.1 Wanbang Biopharmaceuticals Company Information
13.11.2 Wanbang Biopharmaceuticals MET TKIs Product Portfolios and Specifications
13.11.3 Wanbang Biopharmaceuticals MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Wanbang Biopharmaceuticals Main Business Overview
13.11.5 Wanbang Biopharmaceuticals Latest Developments
13.12 Drug International
13.12.1 Drug International Company Information
13.12.2 Drug International MET TKIs Product Portfolios and Specifications
13.12.3 Drug International MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Drug International Main Business Overview
13.12.5 Drug International Latest Developments
13.13 Genvio Pharma
13.13.1 Genvio Pharma Company Information
13.13.2 Genvio Pharma MET TKIs Product Portfolios and Specifications
13.13.3 Genvio Pharma MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Genvio Pharma Main Business Overview
13.13.5 Genvio Pharma Latest Developments
13.14 Everest Pharmaceuticals
13.14.1 Everest Pharmaceuticals Company Information
13.14.2 Everest Pharmaceuticals MET TKIs Product Portfolios and Specifications
13.14.3 Everest Pharmaceuticals MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Everest Pharmaceuticals Main Business Overview
13.14.5 Everest Pharmaceuticals Latest Developments
13.15 Beacom
13.15.1 Beacom Company Information
13.15.2 Beacom MET TKIs Product Portfolios and Specifications
13.15.3 Beacom MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Beacom Main Business Overview
13.15.5 Beacom Latest Developments
13.16 Teva
13.16.1 Teva Company Information
13.16.2 Teva MET TKIs Product Portfolios and Specifications
13.16.3 Teva MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Teva Main Business Overview
13.16.5 Teva Latest Developments
13.17 Cipla
13.17.1 Cipla Company Information
13.17.2 Cipla MET TKIs Product Portfolios and Specifications
13.17.3 Cipla MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Cipla Main Business Overview
13.17.5 Cipla Latest Developments
13.18 BDR Pharma
13.18.1 BDR Pharma Company Information
13.18.2 BDR Pharma MET TKIs Product Portfolios and Specifications
13.18.3 BDR Pharma MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 BDR Pharma Main Business Overview
13.18.5 BDR Pharma Latest Developments
13.19 Zydus
13.19.1 Zydus Company Information
13.19.2 Zydus MET TKIs Product Portfolios and Specifications
13.19.3 Zydus MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Zydus Main Business Overview
13.19.5 Zydus Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global MET TKIs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for MET TKIs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for MET TKIs by Country/Region, 2021, 2025 & 2032
2.2 MET TKIs Segment by Type
2.2.1 Multi-target Inhibitors
2.2.2 Single-target Inhibitors
2.2.3 MET TKIs Sales by Type
2.2.3.1 Global MET TKIs Sales Market Share by Type (2021-2026)
2.2.3.2 Global MET TKIs Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global MET TKIs Sale Price by Type (2021-2026)
2.3 MET TKIs Segment by Application
2.3.1 Non-small Cell Lung Cancer
2.3.2 Medullary Thyroid Cancer
2.3.3 Other
2.3.4 MET TKIs Sales by Application
2.3.4.1 Global MET TKIs Sale Market Share by Application (2021-2026)
2.3.4.2 Global MET TKIs Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global MET TKIs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global MET TKIs Breakdown Data by Company
3.1.1 Global MET TKIs Annual Sales by Company (2021-2026)
3.1.2 Global MET TKIs Sales Market Share by Company (2021-2026)
3.2 Global MET TKIs Annual Revenue by Company (2021-2026)
3.2.1 Global MET TKIs Revenue by Company (2021-2026)
3.2.2 Global MET TKIs Revenue Market Share by Company (2021-2026)
3.3 Global MET TKIs Sale Price by Company
3.4 Key Manufacturers MET TKIs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers MET TKIs Product Location Distribution
3.4.2 Players MET TKIs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MET TKIS BY GEOGRAPHIC REGION
4.1 World Historic MET TKIs Market Size by Geographic Region (2021-2026)
4.1.1 Global MET TKIs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global MET TKIs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic MET TKIs Market Size by Country/Region (2021-2026)
4.2.1 Global MET TKIs Annual Sales by Country/Region (2021-2026)
4.2.2 Global MET TKIs Annual Revenue by Country/Region (2021-2026)
4.3 Americas MET TKIs Sales Growth
4.4 APAC MET TKIs Sales Growth
4.5 Europe MET TKIs Sales Growth
4.6 Middle East & Africa MET TKIs Sales Growth
5 AMERICAS
5.1 Americas MET TKIs Sales by Country
5.1.1 Americas MET TKIs Sales by Country (2021-2026)
5.1.2 Americas MET TKIs Revenue by Country (2021-2026)
5.2 Americas MET TKIs Sales by Type (2021-2026)
5.3 Americas MET TKIs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC MET TKIs Sales by Region
6.1.1 APAC MET TKIs Sales by Region (2021-2026)
6.1.2 APAC MET TKIs Revenue by Region (2021-2026)
6.2 APAC MET TKIs Sales by Type (2021-2026)
6.3 APAC MET TKIs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe MET TKIs by Country
7.1.1 Europe MET TKIs Sales by Country (2021-2026)
7.1.2 Europe MET TKIs Revenue by Country (2021-2026)
7.2 Europe MET TKIs Sales by Type (2021-2026)
7.3 Europe MET TKIs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa MET TKIs by Country
8.1.1 Middle East & Africa MET TKIs Sales by Country (2021-2026)
8.1.2 Middle East & Africa MET TKIs Revenue by Country (2021-2026)
8.2 Middle East & Africa MET TKIs Sales by Type (2021-2026)
8.3 Middle East & Africa MET TKIs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of MET TKIs
10.3 Manufacturing Process Analysis of MET TKIs
10.4 Industry Chain Structure of MET TKIs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 MET TKIs Distributors
11.3 MET TKIs Customer
12 WORLD FORECAST REVIEW FOR MET TKIS BY GEOGRAPHIC REGION
12.1 Global MET TKIs Market Size Forecast by Region
12.1.1 Global MET TKIs Forecast by Region (2027-2032)
12.1.2 Global MET TKIs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global MET TKIs Forecast by Type (2027-2032)
12.7 Global MET TKIs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer MET TKIs Product Portfolios and Specifications
13.1.3 Pfizer MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis MET TKIs Product Portfolios and Specifications
13.2.3 Novartis MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck MET TKIs Product Portfolios and Specifications
13.3.3 Merck MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Exelixis
13.4.1 Exelixis Company Information
13.4.2 Exelixis MET TKIs Product Portfolios and Specifications
13.4.3 Exelixis MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Exelixis Main Business Overview
13.4.5 Exelixis Latest Developments
13.5 Haihe Biopharma
13.5.1 Haihe Biopharma Company Information
13.5.2 Haihe Biopharma MET TKIs Product Portfolios and Specifications
13.5.3 Haihe Biopharma MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Haihe Biopharma Main Business Overview
13.5.5 Haihe Biopharma Latest Developments
13.6 CSPC Pharmaceutical
13.6.1 CSPC Pharmaceutical Company Information
13.6.2 CSPC Pharmaceutical MET TKIs Product Portfolios and Specifications
13.6.3 CSPC Pharmaceutical MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 CSPC Pharmaceutical Main Business Overview
13.6.5 CSPC Pharmaceutical Latest Developments
13.7 WuXi STA
13.7.1 WuXi STA Company Information
13.7.2 WuXi STA MET TKIs Product Portfolios and Specifications
13.7.3 WuXi STA MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 WuXi STA Main Business Overview
13.7.5 WuXi STA Latest Developments
13.8 Shanghai Hutchison Pharmaceuticals
13.8.1 Shanghai Hutchison Pharmaceuticals Company Information
13.8.2 Shanghai Hutchison Pharmaceuticals MET TKIs Product Portfolios and Specifications
13.8.3 Shanghai Hutchison Pharmaceuticals MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Shanghai Hutchison Pharmaceuticals Main Business Overview
13.8.5 Shanghai Hutchison Pharmaceuticals Latest Developments
13.9 Avistone Pharmaceuticals Biotechnology
13.9.1 Avistone Pharmaceuticals Biotechnology Company Information
13.9.2 Avistone Pharmaceuticals Biotechnology MET TKIs Product Portfolios and Specifications
13.9.3 Avistone Pharmaceuticals Biotechnology MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Avistone Pharmaceuticals Biotechnology Main Business Overview
13.9.5 Avistone Pharmaceuticals Biotechnology Latest Developments
13.10 Asymchem
13.10.1 Asymchem Company Information
13.10.2 Asymchem MET TKIs Product Portfolios and Specifications
13.10.3 Asymchem MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Asymchem Main Business Overview
13.10.5 Asymchem Latest Developments
13.11 Wanbang Biopharmaceuticals
13.11.1 Wanbang Biopharmaceuticals Company Information
13.11.2 Wanbang Biopharmaceuticals MET TKIs Product Portfolios and Specifications
13.11.3 Wanbang Biopharmaceuticals MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Wanbang Biopharmaceuticals Main Business Overview
13.11.5 Wanbang Biopharmaceuticals Latest Developments
13.12 Drug International
13.12.1 Drug International Company Information
13.12.2 Drug International MET TKIs Product Portfolios and Specifications
13.12.3 Drug International MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Drug International Main Business Overview
13.12.5 Drug International Latest Developments
13.13 Genvio Pharma
13.13.1 Genvio Pharma Company Information
13.13.2 Genvio Pharma MET TKIs Product Portfolios and Specifications
13.13.3 Genvio Pharma MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Genvio Pharma Main Business Overview
13.13.5 Genvio Pharma Latest Developments
13.14 Everest Pharmaceuticals
13.14.1 Everest Pharmaceuticals Company Information
13.14.2 Everest Pharmaceuticals MET TKIs Product Portfolios and Specifications
13.14.3 Everest Pharmaceuticals MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Everest Pharmaceuticals Main Business Overview
13.14.5 Everest Pharmaceuticals Latest Developments
13.15 Beacom
13.15.1 Beacom Company Information
13.15.2 Beacom MET TKIs Product Portfolios and Specifications
13.15.3 Beacom MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Beacom Main Business Overview
13.15.5 Beacom Latest Developments
13.16 Teva
13.16.1 Teva Company Information
13.16.2 Teva MET TKIs Product Portfolios and Specifications
13.16.3 Teva MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Teva Main Business Overview
13.16.5 Teva Latest Developments
13.17 Cipla
13.17.1 Cipla Company Information
13.17.2 Cipla MET TKIs Product Portfolios and Specifications
13.17.3 Cipla MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Cipla Main Business Overview
13.17.5 Cipla Latest Developments
13.18 BDR Pharma
13.18.1 BDR Pharma Company Information
13.18.2 BDR Pharma MET TKIs Product Portfolios and Specifications
13.18.3 BDR Pharma MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 BDR Pharma Main Business Overview
13.18.5 BDR Pharma Latest Developments
13.19 Zydus
13.19.1 Zydus Company Information
13.19.2 Zydus MET TKIs Product Portfolios and Specifications
13.19.3 Zydus MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Zydus Main Business Overview
13.19.5 Zydus Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. MET TKIs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. MET TKIs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Multi-target Inhibitors
Table 4. Major Players of Single-target Inhibitors
Table 5. Global MET TKIs Sales by Type (2021-2026) & (K Units)
Table 6. Global MET TKIs Sales Market Share by Type (2021-2026)
Table 7. Global MET TKIs Revenue by Type (2021-2026) & ($ million)
Table 8. Global MET TKIs Revenue Market Share by Type (2021-2026)
Table 9. Global MET TKIs Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global MET TKIs Sale by Application (2021-2026) & (K Units)
Table 11. Global MET TKIs Sale Market Share by Application (2021-2026)
Table 12. Global MET TKIs Revenue by Application (2021-2026) & ($ million)
Table 13. Global MET TKIs Revenue Market Share by Application (2021-2026)
Table 14. Global MET TKIs Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global MET TKIs Sales by Company (2021-2026) & (K Units)
Table 16. Global MET TKIs Sales Market Share by Company (2021-2026)
Table 17. Global MET TKIs Revenue by Company (2021-2026) & ($ millions)
Table 18. Global MET TKIs Revenue Market Share by Company (2021-2026)
Table 19. Global MET TKIs Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers MET TKIs Producing Area Distribution and Sales Area
Table 21. Players MET TKIs Products Offered
Table 22. MET TKIs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global MET TKIs Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global MET TKIs Sales Market Share Geographic Region (2021-2026)
Table 27. Global MET TKIs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global MET TKIs Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global MET TKIs Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global MET TKIs Sales Market Share by Country/Region (2021-2026)
Table 31. Global MET TKIs Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global MET TKIs Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas MET TKIs Sales by Country (2021-2026) & (K Units)
Table 34. Americas MET TKIs Sales Market Share by Country (2021-2026)
Table 35. Americas MET TKIs Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas MET TKIs Sales by Type (2021-2026) & (K Units)
Table 37. Americas MET TKIs Sales by Application (2021-2026) & (K Units)
Table 38. APAC MET TKIs Sales by Region (2021-2026) & (K Units)
Table 39. APAC MET TKIs Sales Market Share by Region (2021-2026)
Table 40. APAC MET TKIs Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC MET TKIs Sales by Type (2021-2026) & (K Units)
Table 42. APAC MET TKIs Sales by Application (2021-2026) & (K Units)
Table 43. Europe MET TKIs Sales by Country (2021-2026) & (K Units)
Table 44. Europe MET TKIs Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe MET TKIs Sales by Type (2021-2026) & (K Units)
Table 46. Europe MET TKIs Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa MET TKIs Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa MET TKIs Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa MET TKIs Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa MET TKIs Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of MET TKIs
Table 52. Key Market Challenges & Risks of MET TKIs
Table 53. Key Industry Trends of MET TKIs
Table 54. MET TKIs Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. MET TKIs Distributors List
Table 57. MET TKIs Customer List
Table 58. Global MET TKIs Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global MET TKIs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas MET TKIs Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas MET TKIs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC MET TKIs Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC MET TKIs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe MET TKIs Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe MET TKIs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa MET TKIs Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa MET TKIs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global MET TKIs Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global MET TKIs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global MET TKIs Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global MET TKIs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Pfizer Basic Information, MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 73. Pfizer MET TKIs Product Portfolios and Specifications
Table 74. Pfizer MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Pfizer Main Business
Table 76. Pfizer Latest Developments
Table 77. Novartis Basic Information, MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 78. Novartis MET TKIs Product Portfolios and Specifications
Table 79. Novartis MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Novartis Main Business
Table 81. Novartis Latest Developments
Table 82. Merck Basic Information, MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 83. Merck MET TKIs Product Portfolios and Specifications
Table 84. Merck MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Merck Main Business
Table 86. Merck Latest Developments
Table 87. Exelixis Basic Information, MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 88. Exelixis MET TKIs Product Portfolios and Specifications
Table 89. Exelixis MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Exelixis Main Business
Table 91. Exelixis Latest Developments
Table 92. Haihe Biopharma Basic Information, MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 93. Haihe Biopharma MET TKIs Product Portfolios and Specifications
Table 94. Haihe Biopharma MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Haihe Biopharma Main Business
Table 96. Haihe Biopharma Latest Developments
Table 97. CSPC Pharmaceutical Basic Information, MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 98. CSPC Pharmaceutical MET TKIs Product Portfolios and Specifications
Table 99. CSPC Pharmaceutical MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. CSPC Pharmaceutical Main Business
Table 101. CSPC Pharmaceutical Latest Developments
Table 102. WuXi STA Basic Information, MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 103. WuXi STA MET TKIs Product Portfolios and Specifications
Table 104. WuXi STA MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. WuXi STA Main Business
Table 106. WuXi STA Latest Developments
Table 107. Shanghai Hutchison Pharmaceuticals Basic Information, MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 108. Shanghai Hutchison Pharmaceuticals MET TKIs Product Portfolios and Specifications
Table 109. Shanghai Hutchison Pharmaceuticals MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Shanghai Hutchison Pharmaceuticals Main Business
Table 111. Shanghai Hutchison Pharmaceuticals Latest Developments
Table 112. Avistone Pharmaceuticals Biotechnology Basic Information, MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 113. Avistone Pharmaceuticals Biotechnology MET TKIs Product Portfolios and Specifications
Table 114. Avistone Pharmaceuticals Biotechnology MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Avistone Pharmaceuticals Biotechnology Main Business
Table 116. Avistone Pharmaceuticals Biotechnology Latest Developments
Table 117. Asymchem Basic Information, MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 118. Asymchem MET TKIs Product Portfolios and Specifications
Table 119. Asymchem MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Asymchem Main Business
Table 121. Asymchem Latest Developments
Table 122. Wanbang Biopharmaceuticals Basic Information, MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 123. Wanbang Biopharmaceuticals MET TKIs Product Portfolios and Specifications
Table 124. Wanbang Biopharmaceuticals MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Wanbang Biopharmaceuticals Main Business
Table 126. Wanbang Biopharmaceuticals Latest Developments
Table 127. Drug International Basic Information, MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 128. Drug International MET TKIs Product Portfolios and Specifications
Table 129. Drug International MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Drug International Main Business
Table 131. Drug International Latest Developments
Table 132. Genvio Pharma Basic Information, MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 133. Genvio Pharma MET TKIs Product Portfolios and Specifications
Table 134. Genvio Pharma MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Genvio Pharma Main Business
Table 136. Genvio Pharma Latest Developments
Table 137. Everest Pharmaceuticals Basic Information, MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 138. Everest Pharmaceuticals MET TKIs Product Portfolios and Specifications
Table 139. Everest Pharmaceuticals MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Everest Pharmaceuticals Main Business
Table 141. Everest Pharmaceuticals Latest Developments
Table 142. Beacom Basic Information, MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 143. Beacom MET TKIs Product Portfolios and Specifications
Table 144. Beacom MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Beacom Main Business
Table 146. Beacom Latest Developments
Table 147. Teva Basic Information, MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 148. Teva MET TKIs Product Portfolios and Specifications
Table 149. Teva MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. Teva Main Business
Table 151. Teva Latest Developments
Table 152. Cipla Basic Information, MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 153. Cipla MET TKIs Product Portfolios and Specifications
Table 154. Cipla MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. Cipla Main Business
Table 156. Cipla Latest Developments
Table 157. BDR Pharma Basic Information, MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 158. BDR Pharma MET TKIs Product Portfolios and Specifications
Table 159. BDR Pharma MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 160. BDR Pharma Main Business
Table 161. BDR Pharma Latest Developments
Table 162. Zydus Basic Information, MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 163. Zydus MET TKIs Product Portfolios and Specifications
Table 164. Zydus MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 165. Zydus Main Business
Table 166. Zydus Latest Developments
Table 1. MET TKIs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. MET TKIs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Multi-target Inhibitors
Table 4. Major Players of Single-target Inhibitors
Table 5. Global MET TKIs Sales by Type (2021-2026) & (K Units)
Table 6. Global MET TKIs Sales Market Share by Type (2021-2026)
Table 7. Global MET TKIs Revenue by Type (2021-2026) & ($ million)
Table 8. Global MET TKIs Revenue Market Share by Type (2021-2026)
Table 9. Global MET TKIs Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global MET TKIs Sale by Application (2021-2026) & (K Units)
Table 11. Global MET TKIs Sale Market Share by Application (2021-2026)
Table 12. Global MET TKIs Revenue by Application (2021-2026) & ($ million)
Table 13. Global MET TKIs Revenue Market Share by Application (2021-2026)
Table 14. Global MET TKIs Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global MET TKIs Sales by Company (2021-2026) & (K Units)
Table 16. Global MET TKIs Sales Market Share by Company (2021-2026)
Table 17. Global MET TKIs Revenue by Company (2021-2026) & ($ millions)
Table 18. Global MET TKIs Revenue Market Share by Company (2021-2026)
Table 19. Global MET TKIs Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers MET TKIs Producing Area Distribution and Sales Area
Table 21. Players MET TKIs Products Offered
Table 22. MET TKIs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global MET TKIs Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global MET TKIs Sales Market Share Geographic Region (2021-2026)
Table 27. Global MET TKIs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global MET TKIs Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global MET TKIs Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global MET TKIs Sales Market Share by Country/Region (2021-2026)
Table 31. Global MET TKIs Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global MET TKIs Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas MET TKIs Sales by Country (2021-2026) & (K Units)
Table 34. Americas MET TKIs Sales Market Share by Country (2021-2026)
Table 35. Americas MET TKIs Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas MET TKIs Sales by Type (2021-2026) & (K Units)
Table 37. Americas MET TKIs Sales by Application (2021-2026) & (K Units)
Table 38. APAC MET TKIs Sales by Region (2021-2026) & (K Units)
Table 39. APAC MET TKIs Sales Market Share by Region (2021-2026)
Table 40. APAC MET TKIs Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC MET TKIs Sales by Type (2021-2026) & (K Units)
Table 42. APAC MET TKIs Sales by Application (2021-2026) & (K Units)
Table 43. Europe MET TKIs Sales by Country (2021-2026) & (K Units)
Table 44. Europe MET TKIs Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe MET TKIs Sales by Type (2021-2026) & (K Units)
Table 46. Europe MET TKIs Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa MET TKIs Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa MET TKIs Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa MET TKIs Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa MET TKIs Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of MET TKIs
Table 52. Key Market Challenges & Risks of MET TKIs
Table 53. Key Industry Trends of MET TKIs
Table 54. MET TKIs Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. MET TKIs Distributors List
Table 57. MET TKIs Customer List
Table 58. Global MET TKIs Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global MET TKIs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas MET TKIs Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas MET TKIs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC MET TKIs Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC MET TKIs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe MET TKIs Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe MET TKIs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa MET TKIs Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa MET TKIs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global MET TKIs Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global MET TKIs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global MET TKIs Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global MET TKIs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Pfizer Basic Information, MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 73. Pfizer MET TKIs Product Portfolios and Specifications
Table 74. Pfizer MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Pfizer Main Business
Table 76. Pfizer Latest Developments
Table 77. Novartis Basic Information, MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 78. Novartis MET TKIs Product Portfolios and Specifications
Table 79. Novartis MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Novartis Main Business
Table 81. Novartis Latest Developments
Table 82. Merck Basic Information, MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 83. Merck MET TKIs Product Portfolios and Specifications
Table 84. Merck MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Merck Main Business
Table 86. Merck Latest Developments
Table 87. Exelixis Basic Information, MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 88. Exelixis MET TKIs Product Portfolios and Specifications
Table 89. Exelixis MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Exelixis Main Business
Table 91. Exelixis Latest Developments
Table 92. Haihe Biopharma Basic Information, MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 93. Haihe Biopharma MET TKIs Product Portfolios and Specifications
Table 94. Haihe Biopharma MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Haihe Biopharma Main Business
Table 96. Haihe Biopharma Latest Developments
Table 97. CSPC Pharmaceutical Basic Information, MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 98. CSPC Pharmaceutical MET TKIs Product Portfolios and Specifications
Table 99. CSPC Pharmaceutical MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. CSPC Pharmaceutical Main Business
Table 101. CSPC Pharmaceutical Latest Developments
Table 102. WuXi STA Basic Information, MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 103. WuXi STA MET TKIs Product Portfolios and Specifications
Table 104. WuXi STA MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. WuXi STA Main Business
Table 106. WuXi STA Latest Developments
Table 107. Shanghai Hutchison Pharmaceuticals Basic Information, MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 108. Shanghai Hutchison Pharmaceuticals MET TKIs Product Portfolios and Specifications
Table 109. Shanghai Hutchison Pharmaceuticals MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Shanghai Hutchison Pharmaceuticals Main Business
Table 111. Shanghai Hutchison Pharmaceuticals Latest Developments
Table 112. Avistone Pharmaceuticals Biotechnology Basic Information, MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 113. Avistone Pharmaceuticals Biotechnology MET TKIs Product Portfolios and Specifications
Table 114. Avistone Pharmaceuticals Biotechnology MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Avistone Pharmaceuticals Biotechnology Main Business
Table 116. Avistone Pharmaceuticals Biotechnology Latest Developments
Table 117. Asymchem Basic Information, MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 118. Asymchem MET TKIs Product Portfolios and Specifications
Table 119. Asymchem MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Asymchem Main Business
Table 121. Asymchem Latest Developments
Table 122. Wanbang Biopharmaceuticals Basic Information, MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 123. Wanbang Biopharmaceuticals MET TKIs Product Portfolios and Specifications
Table 124. Wanbang Biopharmaceuticals MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Wanbang Biopharmaceuticals Main Business
Table 126. Wanbang Biopharmaceuticals Latest Developments
Table 127. Drug International Basic Information, MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 128. Drug International MET TKIs Product Portfolios and Specifications
Table 129. Drug International MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Drug International Main Business
Table 131. Drug International Latest Developments
Table 132. Genvio Pharma Basic Information, MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 133. Genvio Pharma MET TKIs Product Portfolios and Specifications
Table 134. Genvio Pharma MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Genvio Pharma Main Business
Table 136. Genvio Pharma Latest Developments
Table 137. Everest Pharmaceuticals Basic Information, MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 138. Everest Pharmaceuticals MET TKIs Product Portfolios and Specifications
Table 139. Everest Pharmaceuticals MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Everest Pharmaceuticals Main Business
Table 141. Everest Pharmaceuticals Latest Developments
Table 142. Beacom Basic Information, MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 143. Beacom MET TKIs Product Portfolios and Specifications
Table 144. Beacom MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Beacom Main Business
Table 146. Beacom Latest Developments
Table 147. Teva Basic Information, MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 148. Teva MET TKIs Product Portfolios and Specifications
Table 149. Teva MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. Teva Main Business
Table 151. Teva Latest Developments
Table 152. Cipla Basic Information, MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 153. Cipla MET TKIs Product Portfolios and Specifications
Table 154. Cipla MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. Cipla Main Business
Table 156. Cipla Latest Developments
Table 157. BDR Pharma Basic Information, MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 158. BDR Pharma MET TKIs Product Portfolios and Specifications
Table 159. BDR Pharma MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 160. BDR Pharma Main Business
Table 161. BDR Pharma Latest Developments
Table 162. Zydus Basic Information, MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 163. Zydus MET TKIs Product Portfolios and Specifications
Table 164. Zydus MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 165. Zydus Main Business
Table 166. Zydus Latest Developments
LIST OF FIGURES
Figure 1. Picture of MET TKIs
Figure 2. MET TKIs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global MET TKIs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global MET TKIs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. MET TKIs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. MET TKIs Sales Market Share by Country/Region (2025)
Figure 10. MET TKIs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Multi-target Inhibitors
Figure 12. Product Picture of Single-target Inhibitors
Figure 13. Global MET TKIs Sales Market Share by Type in 2026
Figure 14. Global MET TKIs Revenue Market Share by Type (2021-2026)
Figure 15. MET TKIs Consumed in Non-small Cell Lung Cancer
Figure 16. Global MET TKIs Market: Non-small Cell Lung Cancer (2021-2026) & (K Units)
Figure 17. MET TKIs Consumed in Medullary Thyroid Cancer
Figure 18. Global MET TKIs Market: Medullary Thyroid Cancer (2021-2026) & (K Units)
Figure 19. MET TKIs Consumed in Other
Figure 20. Global MET TKIs Market: Other (2021-2026) & (K Units)
Figure 21. Global MET TKIs Sale Market Share by Application (2025)
Figure 22. Global MET TKIs Revenue Market Share by Application in 2026
Figure 23. MET TKIs Sales by Company in 2026 (K Units)
Figure 24. Global MET TKIs Sales Market Share by Company in 2026
Figure 25. MET TKIs Revenue by Company in 2026 ($ millions)
Figure 26. Global MET TKIs Revenue Market Share by Company in 2026
Figure 27. Global MET TKIs Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global MET TKIs Revenue Market Share by Geographic Region in 2026
Figure 29. Americas MET TKIs Sales 2021-2026 (K Units)
Figure 30. Americas MET TKIs Revenue 2021-2026 ($ millions)
Figure 31. APAC MET TKIs Sales 2021-2026 (K Units)
Figure 32. APAC MET TKIs Revenue 2021-2026 ($ millions)
Figure 33. Europe MET TKIs Sales 2021-2026 (K Units)
Figure 34. Europe MET TKIs Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa MET TKIs Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa MET TKIs Revenue 2021-2026 ($ millions)
Figure 37. Americas MET TKIs Sales Market Share by Country in 2026
Figure 38. Americas MET TKIs Revenue Market Share by Country (2021-2026)
Figure 39. Americas MET TKIs Sales Market Share by Type (2021-2026)
Figure 40. Americas MET TKIs Sales Market Share by Application (2021-2026)
Figure 41. United States MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC MET TKIs Sales Market Share by Region in 2026
Figure 46. APAC MET TKIs Revenue Market Share by Region (2021-2026)
Figure 47. APAC MET TKIs Sales Market Share by Type (2021-2026)
Figure 48. APAC MET TKIs Sales Market Share by Application (2021-2026)
Figure 49. China MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 53. India MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe MET TKIs Sales Market Share by Country in 2026
Figure 57. Europe MET TKIs Revenue Market Share by Country (2021-2026)
Figure 58. Europe MET TKIs Sales Market Share by Type (2021-2026)
Figure 59. Europe MET TKIs Sales Market Share by Application (2021-2026)
Figure 60. Germany MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 61. France MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 62. UK MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa MET TKIs Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa MET TKIs Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa MET TKIs Sales Market Share by Application (2021-2026)
Figure 68. Egypt MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of MET TKIs in 2026
Figure 74. Manufacturing Process Analysis of MET TKIs
Figure 75. Industry Chain Structure of MET TKIs
Figure 76. Channels of Distribution
Figure 77. Global MET TKIs Sales Market Forecast by Region (2027-2032)
Figure 78. Global MET TKIs Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global MET TKIs Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global MET TKIs Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global MET TKIs Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global MET TKIs Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of MET TKIs
Figure 2. MET TKIs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global MET TKIs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global MET TKIs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. MET TKIs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. MET TKIs Sales Market Share by Country/Region (2025)
Figure 10. MET TKIs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Multi-target Inhibitors
Figure 12. Product Picture of Single-target Inhibitors
Figure 13. Global MET TKIs Sales Market Share by Type in 2026
Figure 14. Global MET TKIs Revenue Market Share by Type (2021-2026)
Figure 15. MET TKIs Consumed in Non-small Cell Lung Cancer
Figure 16. Global MET TKIs Market: Non-small Cell Lung Cancer (2021-2026) & (K Units)
Figure 17. MET TKIs Consumed in Medullary Thyroid Cancer
Figure 18. Global MET TKIs Market: Medullary Thyroid Cancer (2021-2026) & (K Units)
Figure 19. MET TKIs Consumed in Other
Figure 20. Global MET TKIs Market: Other (2021-2026) & (K Units)
Figure 21. Global MET TKIs Sale Market Share by Application (2025)
Figure 22. Global MET TKIs Revenue Market Share by Application in 2026
Figure 23. MET TKIs Sales by Company in 2026 (K Units)
Figure 24. Global MET TKIs Sales Market Share by Company in 2026
Figure 25. MET TKIs Revenue by Company in 2026 ($ millions)
Figure 26. Global MET TKIs Revenue Market Share by Company in 2026
Figure 27. Global MET TKIs Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global MET TKIs Revenue Market Share by Geographic Region in 2026
Figure 29. Americas MET TKIs Sales 2021-2026 (K Units)
Figure 30. Americas MET TKIs Revenue 2021-2026 ($ millions)
Figure 31. APAC MET TKIs Sales 2021-2026 (K Units)
Figure 32. APAC MET TKIs Revenue 2021-2026 ($ millions)
Figure 33. Europe MET TKIs Sales 2021-2026 (K Units)
Figure 34. Europe MET TKIs Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa MET TKIs Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa MET TKIs Revenue 2021-2026 ($ millions)
Figure 37. Americas MET TKIs Sales Market Share by Country in 2026
Figure 38. Americas MET TKIs Revenue Market Share by Country (2021-2026)
Figure 39. Americas MET TKIs Sales Market Share by Type (2021-2026)
Figure 40. Americas MET TKIs Sales Market Share by Application (2021-2026)
Figure 41. United States MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC MET TKIs Sales Market Share by Region in 2026
Figure 46. APAC MET TKIs Revenue Market Share by Region (2021-2026)
Figure 47. APAC MET TKIs Sales Market Share by Type (2021-2026)
Figure 48. APAC MET TKIs Sales Market Share by Application (2021-2026)
Figure 49. China MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 53. India MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe MET TKIs Sales Market Share by Country in 2026
Figure 57. Europe MET TKIs Revenue Market Share by Country (2021-2026)
Figure 58. Europe MET TKIs Sales Market Share by Type (2021-2026)
Figure 59. Europe MET TKIs Sales Market Share by Application (2021-2026)
Figure 60. Germany MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 61. France MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 62. UK MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa MET TKIs Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa MET TKIs Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa MET TKIs Sales Market Share by Application (2021-2026)
Figure 68. Egypt MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of MET TKIs in 2026
Figure 74. Manufacturing Process Analysis of MET TKIs
Figure 75. Industry Chain Structure of MET TKIs
Figure 76. Channels of Distribution
Figure 77. Global MET TKIs Sales Market Forecast by Region (2027-2032)
Figure 78. Global MET TKIs Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global MET TKIs Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global MET TKIs Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global MET TKIs Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global MET TKIs Revenue Market Share Forecast by Application (2027-2032)
